Clinical trials
Sarcopenia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 5 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Terminated | 3 |
| Suspended | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McMaster University | 9 |
| University of Saskatchewan | 8 |
| University of Toronto | 3 |
| University of Calgary | 2 |
| Université du Québec a Montréal | 2 |
| AHS Cancer Control Alberta | 1 |
| Amazentis SA | 1 |
| Axcella Health, Inc | 1 |
| British Columbia Cancer Agency | 1 |
| Dr. Chris McGlory, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcopenia | 39 |
| Frailty | 4 |
| Muscular Atrophy | 4 |
| Osteoporosis | 4 |
| Inflammation | 3 |
| Liver Cirrhosis | 2 |
| Atrophy | 1 |
| Cachexia | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Critical Illness | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.